The adage ‘teamwork makes the dream work’ rings especially true in the dynamic realm of biotech startups. Most successful biotech companies have a foundation built on a robust relationship between their founders and venture capital (VC) partners. This founder-VC partnership represents a symbiotic relationship between a venture capital firm and the founding team of a biotech startup. But what are the key factors for a successful partnership?
An ageing population comes with multiple challenges. Diseases affecting older populations are becoming more prevalent shifting the focus of our healthcare systems. One of the most debilitating is Alzheimer’s disease. Although there is currently no cure, groundbreaking research is expanding our knowledge, giving hope to patients.
Anacura, a Ghent-based company offering medical and pharmaceutical analytical services, announces the acquisition of OHMX.bio, a Ghent University spin-off specialized in advanced -omics technology. The acquisition expands the existing anacura group activities at AnaBioTec and Labo Nuytinck towards drug discovery and diagnostics research.
The appointments of Dr. Alain Pluquet as Chairman of the Board and Mr. Michael Tillmann as Independent Director brings extensive industrial expertise to help develop Axithra’s long-term strategy
An estimated 50 million people in Europe regularly go for a run, including almost 20% of the Belgian population. While most might not be running marathons at an Olympic pace, the chance of getting injured can feel inevitable to any runner. This fear is justified, as around half of all runners experience at least one injury annually. But what’s driving this unsettling statistic, and how can runners potentially reduce the likelihood of a dreaded injury spell?
For scientists or budding entrepreneurs with the next big idea in sports tech, the road from conceptualization to product can seem perilous, with many pitfalls along the way. To stand a chance at getting your research out of the lab and into the hands of athletes, it’s essential to start off on the right foot.
Read on to see how the collaboration of scientists and sports tech development experts is helping this unique ecosystem in Belgium to flourish.
Children increasingly seek the comfort and entertainment of television, tablets and smartphones rather than playing outside. This reduction in physical activity has accelerated over the last few decades and has detrimental effects for children later in life. They are the future, so studying their development and lifestyle gives us a forecast of where we are heading. Are we moving towards a sedentary population? And if so, how can we alter our course?
Training session after training session, top athletes must push themselves to the limits to test their bodies. Although pain is a clear emergency signal, athletes in pain may push themselves even further. This makes them vulnerable to injuries and severe pain conditions including acute and chronic lower back pain. Although there are several treatment options to alleviate the symptoms, the treatment of acute and chronic pain is not straightforward. A multidisciplinary approach is required, and more treatment options are needed that focus on treating the underlying cause.
The adage ‘teamwork makes the dream work’ rings especially true in the dynamic realm of biotech startups. Most successful biotech companies have a foundation built on a robust relationship between their founders and venture capital (VC) partners. This founder-VC partnership represents a symbiotic relationship between a venture capital firm and the founding team of a biotech startup. But what are the key factors for a successful partnership?
An ageing population comes with multiple challenges. Diseases affecting older populations are becoming more prevalent shifting the focus of our healthcare systems. One of the most debilitating is Alzheimer’s disease. Although there is currently no cure, groundbreaking research is expanding our knowledge, giving hope to patients.
Anacura, a Ghent-based company offering medical and pharmaceutical analytical services, announces the acquisition of OHMX.bio, a Ghent University spin-off specialized in advanced -omics technology. The acquisition expands the existing anacura group activities at AnaBioTec and Labo Nuytinck towards drug discovery and diagnostics research.
The appointments of Dr. Alain Pluquet as Chairman of the Board and Mr. Michael Tillmann as Independent Director brings extensive industrial expertise to help develop Axithra’s long-term strategy
An estimated 50 million people in Europe regularly go for a run, including almost 20% of the Belgian population. While most might not be running marathons at an Olympic pace, the chance of getting injured can feel inevitable to any runner. This fear is justified, as around half of all runners experience at least one injury annually. But what’s driving this unsettling statistic, and how can runners potentially reduce the likelihood of a dreaded injury spell?
For scientists or budding entrepreneurs with the next big idea in sports tech, the road from conceptualization to product can seem perilous, with many pitfalls along the way. To stand a chance at getting your research out of the lab and into the hands of athletes, it’s essential to start off on the right foot.
Read on to see how the collaboration of scientists and sports tech development experts is helping this unique ecosystem in Belgium to flourish.
Children increasingly seek the comfort and entertainment of television, tablets and smartphones rather than playing outside. This reduction in physical activity has accelerated over the last few decades and has detrimental effects for children later in life. They are the future, so studying their development and lifestyle gives us a forecast of where we are heading. Are we moving towards a sedentary population? And if so, how can we alter our course?
Training session after training session, top athletes must push themselves to the limits to test their bodies. Although pain is a clear emergency signal, athletes in pain may push themselves even further. This makes them vulnerable to injuries and severe pain conditions including acute and chronic lower back pain. Although there are several treatment options to alleviate the symptoms, the treatment of acute and chronic pain is not straightforward. A multidisciplinary approach is required, and more treatment options are needed that focus on treating the underlying cause.